Skip to main content

Table 2 Univariate analysis according to one-year outcome

From: Functional outcome of prolonged refractory status epilepticus

 

Good outcome (mRS ≤3) n = 12

Poor outcome (mRS >3) n = 51a

P -value

Male gender

9 (75)

30 (58.8)

0.01

Age, years

42 (31 to 62)]

58 (45 to 71)

0.07

Simplified acute physiology score II

46.9 ± 12.8

53.9 ± 15.4

0.65

Admission mRS

0.5 (0 to 1)

1 (0 to 2)

0.16

Known cause of PRSE

7 (58.3)

31 (60.8)

0.57

Thiopental for general anesthesia

11 (91.7)

47 (92.1)

0.55

EEG burst suppression within 7 days

9 (75)

32 (62.7)

0.054

Status epilpticus duration, days

15 (11 to 37)

17 (11 to 22)

0.95

Length of ICU stay, days

35 (20 to 49)

25 (14 to 45)

0.38

Etiological treatment

8 (66.7)

22 (43.1)

0.0003

Vasopressors

4 (33.3)

32 (62.7)

<0.0001

Nosocomial infections

10 (83.3)

38 (74.5)

0.14

Seizures after ICU discharge

3 (25)

5 (35.7)

0.27

ICU-acquired polyneuropathy

6 (50)

8 (57.1)b

0.59

  1. Data are number (%), mean ± SD or median (IQR). aPatients with complete available data; bonly in ICU survivors. mRS, modified Rankin scale; PRSE, prolonged refractory status epilepticus; EEG, electroencephalogram.